Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Altered calcium homeostasis in autism-spectrum disorders: evidence from biochemical and genetic studies of the mitochondrial aspartate/glutamate carrier AGC1
Luigi Palmieri, Veruska Papaleo, Vito Porcelli, et al.
Molecular Psychiatry (2008) Vol. 15, Iss. 1, pp. 38-52
Closed Access | Times Cited: 199

Showing 1-25 of 199 citing articles:

Mitochondrial dysfunction in autism spectrum disorders: a systematic review and meta-analysis
Daniel A. Rossignol, Richard E. Frye
Molecular Psychiatry (2011) Vol. 17, Iss. 3, pp. 290-314
Open Access | Times Cited: 813
Energetics, epigenetics, mitochondrial genetics
Douglas C. Wallace, Weiwei Fan
Mitochondrion (2009) Vol. 10, Iss. 1, pp. 12-31
Open Access | Times Cited: 485
Evidence linking oxidative stress, mitochondrial dysfunction, and inflammation in the brain of individuals with autism
Daniel A. Rossignol, Richard E. Frye
Frontiers in Physiology (2014) Vol. 5
Open Access | Times Cited: 328
A mitochondrial bioenergetic etiology of disease
Douglas C. Wallace
Journal of Clinical Investigation (2013) Vol. 123, Iss. 4, pp. 1405-1412
Open Access | Times Cited: 314
The many roads to mitochondrial dysfunction in neuroimmune and neuropsychiatric disorders
Gerwyn Morris, Michael Berk
BMC Medicine (2015) Vol. 13, Iss. 1
Open Access | Times Cited: 222
Reduction in parvalbumin expression not loss of the parvalbumin-expressing GABA interneuron subpopulation in genetic parvalbumin and shank mouse models of autism
Federica Filice, Karl Jakob Vörckel, Ayse Özge Sungur, et al.
Molecular Brain (2016) Vol. 9, Iss. 1
Open Access | Times Cited: 220
Clinical and Molecular Characteristics of Mitochondrial Dysfunction in Autism Spectrum Disorder
Shannon Rose, Dmitriy Niyazov, Daniel A. Rossignol, et al.
Molecular Diagnosis & Therapy (2018) Vol. 22, Iss. 5, pp. 571-593
Open Access | Times Cited: 201
The neuropathology of autism: A systematic review of post-mortem studies of autism and related disorders
Rana Fetit, Robert F. Hillary, David J. Price, et al.
Neuroscience & Biobehavioral Reviews (2021) Vol. 129, pp. 35-62
Open Access | Times Cited: 104
Brain region‐specific deficit in mitochondrial electron transport chain complexes in children with autism
Abha Chauhan, Gu Feng, Musthafa Mohamed Essa, et al.
Journal of Neurochemistry (2011) Vol. 117, Iss. 2, pp. 209-220
Open Access | Times Cited: 223
Mitochondrial dysfunction in autism spectrum disorders: Cause or effect?
Luigi Palmieri, Antonio M. Persico
Biochimica et Biophysica Acta (BBA) - Bioenergetics (2010) Vol. 1797, Iss. 6-7, pp. 1130-1137
Open Access | Times Cited: 167
Antipurinergic Therapy Corrects the Autism-Like Features in the Poly(IC) Mouse Model
Robert K. Naviaux, Zarazuela Zolkipli, Lin Wang, et al.
PLoS ONE (2013) Vol. 8, Iss. 3, pp. e57380-e57380
Open Access | Times Cited: 159
Gastrointestinal dysfunction in autism spectrum disorder: the role of the mitochondria and the enteric microbiome
Richard E. Frye, Shannon Rose, John M. Slattery, et al.
Microbial Ecology in Health and Disease (2015) Vol. 26
Open Access | Times Cited: 132
Brain region-specific altered expression and association of mitochondria-related genes in autism
Ayyappan Anitha, Kazuhiko Nakamura, Ismail Thanseem, et al.
Molecular Autism (2012) Vol. 3, Iss. 1
Open Access | Times Cited: 132
Metabolic Dysfunction Underlying Autism Spectrum Disorder and Potential Treatment Approaches
Ning Cheng, Jong M. Rho, Susan A. Masino
Frontiers in Molecular Neuroscience (2017) Vol. 10
Open Access | Times Cited: 126
Fluorescent nanodiamond tracking reveals intraneuronal transport abnormalities induced by brain-disease-related genetic risk factors
Simon Haziza, Nitin Mohan, Yann Loe-Mie, et al.
Nature Nanotechnology (2016) Vol. 12, Iss. 4, pp. 322-328
Open Access | Times Cited: 125
Mitochondrial Dysfunction in Autism Spectrum Disorder: Unique Abnormalities and Targeted Treatments
Richard E. Frye
Seminars in Pediatric Neurology (2020) Vol. 35, pp. 100829-100829
Open Access | Times Cited: 124
Glutamate mediated signaling in the pathophysiology of autism spectrum disorders
Paromita Roy Choudhury, Sanjukta Lahiri, Usha Rajamma
Pharmacology Biochemistry and Behavior (2011) Vol. 100, Iss. 4, pp. 841-849
Closed Access | Times Cited: 115
Channelopathy pathogenesis in autism spectrum disorders
Galina Schmunk, J. Jay Gargus
Frontiers in Genetics (2013) Vol. 4
Open Access | Times Cited: 113
Advancing the science of developmental neurotoxicity (DNT): testing for better safety evaluation
Anna Bal‐Price
ALTEX (2012) Vol. 29, Iss. 2, pp. 202-215
Open Access | Times Cited: 113
Mitochondrial Dysfunction in Autism Spectrum Disorders
M SIDDIQUI, Clare E. Elwell, Mark H. Johnson
Autism - Open Access (2016) Vol. 6, Iss. 4
Open Access | Times Cited: 113
Mitochondrial dysfunction in Autism Spectrum Disorder: clinical features and perspectives
Fiona Hollis, Alexandros K. Kanellopoulos, Claudia Bagni
Current Opinion in Neurobiology (2017) Vol. 45, pp. 178-187
Closed Access | Times Cited: 112
AGC1/2, the mitochondrial aspartate-glutamate carriers
Nívea Dias Amoêdo, Giuseppe Punzi, Émilie Obre, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Cell Research (2016) Vol. 1863, Iss. 10, pp. 2394-2412
Open Access | Times Cited: 100
Mitochondria as pharmacological targets in Down syndrome
Daniela Valenti, Nady Braidy, Domenico De Rasmo, et al.
Free Radical Biology and Medicine (2017) Vol. 114, pp. 69-83
Closed Access | Times Cited: 97
Cellular stress and apoptosis contribute to the pathogenesis of autism spectrum disorder
Daoyin Dong, H. Ronald Zielke, David Yeh, et al.
Autism Research (2018) Vol. 11, Iss. 7, pp. 1076-1090
Open Access | Times Cited: 95
Cerebral Folate Deficiency, Folate Receptor Alpha Autoantibodies and Leucovorin (Folinic Acid) Treatment in Autism Spectrum Disorders: A Systematic Review and Meta-Analysis
Daniel A. Rossignol, Richard E. Frye
Journal of Personalized Medicine (2021) Vol. 11, Iss. 11, pp. 1141-1141
Open Access | Times Cited: 58
Page 1 - Next Page

Scroll to top